NeoGenomics, Inc.: NeoGenomics Reports Revenue of $125 Million in the Second Quarter
Second-Quarter 2022 Results and HighlightsConsolidated revenue increased 3% to $125 millionClinical Services revenue increased 4% to $106 millionPharma Services revenue decreased 4% to $19 millionChris
Source: finanznachrichten.de